Indication

Malignant essential hypertension

Malignant essential hypertension is an acute, life-threatening hypertensive emergency that arises from severe, idiopathic (primary) systemic high blood pressure. Read more about Malignant essential hypertension

3 drugs 3 manufacturers

Advertisement

Drugs that treat it

Common Malignant essential hypertension therapies.

Showing 1–3 of 3 drugs

Filter & compare in the drug finder →Opens the drug finder with Malignant essential hypertension preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Malignant essential hypertension.

Malignant essential hypertension is an acute, life-threatening hypertensive emergency that arises from severe, idiopathic (primary) systemic high blood pressure.

It primarily affects the cardiovascular, renal, ocular, and central nervous systems, frequently presenting in adults with chronic or inadequately controlled underlying hypertension.

Pathophysiologically, it is driven by a breakdown in vascular autoregulation and severe endothelial injury, leading to widespread arteriolar fibrinoid necrosis and microvascular ischemia.

The defining clinical hallmark is extreme arterial blood pressure elevation—commonly exceeding a systolic pressure of 200 mm Hg or diastolic pressure of 120 to 130 mm Hg—accompanied by advanced bilateral retinopathy (flame-shaped hemorrhages, cotton-wool exudates, or papilledema) and rapidly progressive target-organ damage such as acute kidney injury, hypertensive encephalopathy, or heart failure.

Personalize your experience

Follow Malignant essential hypertension and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it